Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

In this position statement of the ESC Working Group on Myocardial and Pericardial Diseases an expert consensus group reviews the current knowledge on clinical presentation, diagnosis and treatment of myocarditis, and proposes new diagnostic criteria for clinically suspected myocarditis and its distinct biopsy-proven pathogenetic forms. The aims are to bridge the gap between clinical and tissue-based diagnosis, to improve management and provide a common reference point for future registries and multicentre randomised controlled trials of aetiology-driven treatment in inflammatory heart muscle disease.

[1]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[2]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[3]  Gerhard Hindricks,et al.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  Jeroen J. Bax,et al.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. , 2012, European heart journal.

[5]  H. Schultheiss,et al.  Interferon-Beta improves survival in enterovirus-associated cardiomyopathy. , 2012, Journal of the American College of Cardiology.

[6]  A. Angelini,et al.  2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. , 2012, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[7]  K. Klingel,et al.  Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. , 2012, Journal of the American College of Cardiology.

[8]  L. Cooper,et al.  Update on myocarditis. , 2012, Journal of the American College of Cardiology.

[9]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[10]  L. Cooper,et al.  The management of myocarditis. , 2011, European heart journal.

[11]  N. Chi,et al.  Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center's experience. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[12]  H. Ohira,et al.  18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  R. Lazzara,et al.  Opposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases. , 2011, International journal of cardiology.

[14]  A. Pavie,et al.  Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support* , 2011, Critical care medicine.

[15]  M. Böhm,et al.  Prognostic electrocardiographic parameters in patients with suspected myocarditis , 2011, European journal of heart failure.

[16]  M. Böhm,et al.  Virus serology in patients with suspected myocarditis: utility or futility? , 2011, European heart journal.

[17]  W. Shen,et al.  HLA-DR4 antigen and idiopathic dilated cardiomyopathy susceptibility: a meta-analysis involving 11,761 subjects. , 2011, Tissue antigens.

[18]  Finn Gustafsson,et al.  2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .

[19]  M. Cheitlin.  Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis , 2011 .

[20]  J Taylor,et al.  Focused update of the ESC Guidelines on device therapy in heart failure. , 2010, European heart journal.

[21]  A. Camm,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, European heart journal.

[22]  Jeroen J. Bax,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[23]  M. Schieber,et al.  Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy: Differences in Complication Rate and Diagnostic Performance , 2010, Circulation.

[24]  S. Felix,et al.  Immunoadsorption in dilated cardiomyopathy: long‐term reduction of cardiodepressant antibodies , 2010, European journal of clinical investigation.

[25]  S. Felix,et al.  Cardiac β1‐adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre‐Course, and Survival (ETiCS) Study , 2010, European journal of heart failure.

[26]  Rosemary C. She,et al.  Utility of immunofluorescence and electron microscopy in endomyocardial biopsies from patients with unexplained heart failure. , 2010, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[27]  K. Klingel,et al.  Human parvovirus B19-associated myocarditis. , 2010, The New England journal of medicine.

[28]  W. Hoffmann,et al.  Fcγ‐Receptor IIa Polymorphism and the Role of Immunoadsorption in Cardiac Dysfunction in Patients With Dilated Cardiomyopathy , 2010, Clinical pharmacology and therapeutics.

[29]  O. Hammarsten,et al.  Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio , 2010, Clinical Research in Cardiology.

[30]  H. Figulla,et al.  Successful use of a wearable cardioverter-defibrillator in myocarditis with normal ejection fraction , 2010, Clinical Research in Cardiology.

[31]  K. Klingel,et al.  Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. , 2009, European heart journal.

[32]  K. Klingel,et al.  Imaging in inflammatory heart disease: from the past to current clinical practice. , 2009, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[33]  N. Rose.  Myocarditis: Infection Versus Autoimmunity , 2009, Journal of Clinical Immunology.

[34]  F. Spinale,et al.  Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure. , 2009, Biomarkers in medicine.

[35]  Andrea Frustaci,et al.  Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. , 2009, European heart journal.

[36]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[37]  M. Emdin,et al.  Old and new biomarkers of heart failure , 2009, European journal of heart failure.

[38]  K. Bailey,et al.  Usefulness of immunosuppression for giant cell myocarditis. , 2008, The American journal of cardiology.

[39]  W. Hoffmann,et al.  Complication Rate of Right Ventricular Endomyocardial Biopsy via the Femoral Approach: A Retrospective and Prospective Study Analyzing 3048 Diagnostic Procedures Over an 11-Year Period , 2008, Circulation.

[40]  Michael Böhm,et al.  Predictors of Outcome in Patients With Suspected Myocarditis , 2008, Circulation.

[41]  S. Heymans,et al.  Acute viral myocarditis , 2008, European heart journal.

[42]  U. Völker,et al.  Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy. , 2008, American heart journal.

[43]  G. Lagoumintzis,et al.  Antigen‐specific Apheresis of Pathogenic Autoantibodies from Myasthenia Gravis Sera , 2008, Annals of the New York Academy of Sciences.

[44]  A. Remppis,et al.  Absence of Auto‐Antibodies against Cardiac Troponin I Predicts Improvement of Left Ventricular Function after Acute Myocardial Infarction , 2008, European heart journal.

[45]  M. Gutberlet,et al.  Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. , 2008, Radiology.

[46]  Peter Kellman,et al.  ACUT2E TSE‐SSFP: A hybrid method for T2‐weighted imaging of edema in the heart , 2008, Magnetic resonance in medicine.

[47]  K. Klingel,et al.  Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis , 2008, Heart.

[48]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[49]  Renu Virmani,et al.  A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .

[50]  J. Daubert,et al.  Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. , 2007, European heart journal.

[51]  Richard Sutton,et al.  Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[52]  D. Corrado,et al.  Myocarditis and dilated cardiomyopathy in athletes: diagnosis, management, and recommendations for sport activity. , 2007, Cardiology clinics.

[53]  C. Angermann,et al.  A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure. , 2007, Journal of the American College of Cardiology.

[54]  A. Angelini,et al.  A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. , 2007, European heart journal.

[55]  L. Cooper,et al.  Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice. , 2007, Journal of molecular and cellular cardiology.

[56]  S. Heymans.  Myocarditis and heart failure: need for better diagnostic, predictive, and therapeutic tools. , 2007, European heart journal.

[57]  G. Keren,et al.  Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. , 2007, International journal of cardiology.

[58]  S. Felix,et al.  Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[59]  Peter P. Liu,et al.  Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity. , 2006, Circulation.

[60]  P. Elliott,et al.  Prospective Familial Assessment in Dilated Cardiomyopathy: Cardiac Autoantibodies Predict Disease Development in Asymptomatic Relatives , 2006, Circulation.

[61]  J. Ornato,et al.  [ACC/AHA/ESC 2006 guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary]. , 2006, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[62]  Duan Zhong-dong.  Contemporary Definitions and Classification of Cardiomyopathies , 2007 .

[63]  Stanley D. Kosanke,et al.  Mimicry and Antibody-Mediated Cell Signaling in Autoimmune Myocarditis1 , 2006, The Journal of Immunology.

[64]  S. Colan,et al.  Incidence, causes, and outcomes of dilated cardiomyopathy in children. , 2006, JAMA.

[65]  M. Andrassy,et al.  Cardiac Troponin I but Not Cardiac Troponin T Induces Severe Autoimmune Inflammation in the Myocardium , 2006, Circulation.

[66]  K. Klingel,et al.  Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis , 2006, Circulation.

[67]  Stefan Störk,et al.  Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. , 2006, American heart journal.

[68]  D. McDermott,et al.  CCR5: no longer a "good for nothing" gene--chemokine control of West Nile virus infection. , 2006, Trends in immunology.

[69]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[70]  M. Yacoub,et al.  Human cardiac myosin autoantibodies impair myocyte contractility: a cause‐and‐effect relationship , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[71]  J. Orange,et al.  Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. , 2006, The Journal of allergy and clinical immunology.

[72]  J. Magnani,et al.  Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. , 2006, American heart journal.

[73]  K. Baughman.  Diagnosis of myocarditis: death of Dallas criteria. , 2006, Circulation.

[74]  U. Eriksson,et al.  MyD88 Signaling Controls Autoimmune Myocarditis Induction , 2006, Circulation.

[75]  M. Lohse,et al.  beta(1)-Adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy. , 2006, Trends in cardiovascular medicine.

[76]  J. Ornato,et al.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidel , 2006, European heart journal.

[77]  H. Schultheiss,et al.  Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction , 2005, Circulation.

[78]  B. Maisch,et al.  Inflammatory Dilated Cardiomyopathy (DCMI) , 2005, Herz Kardiovaskuläre Erkrankungen.

[79]  Diethelm Wallwiener,et al.  High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. , 2005, American journal of obstetrics and gynecology.

[80]  J. Schulz-Menger,et al.  Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. , 2005, Journal of the American College of Cardiology.

[81]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[82]  R. Kandolf,et al.  High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With “Idiopathic” Left Ventricular Dysfunction , 2005, Circulation.

[83]  K. Broman,et al.  Two Autoimmune Diabetes Loci Influencing T Cell Apoptosis Control Susceptibility to Experimental Autoimmune Myocarditis1 , 2005, The Journal of Immunology.

[84]  G. Baumann,et al.  Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[85]  S. Ogawa,et al.  Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. , 2004, European heart journal.

[86]  R. Hruban,et al.  Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. , 2004, American heart journal.

[87]  Udo Sechtem,et al.  Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology , 2004, Circulation.

[88]  M. Fu.  Characterization of anti-heart M2 muscarinic receptor antibodies — a combined clinical and experimental study , 1996, Molecular and Cellular Biochemistry.

[89]  Lukas Hunziker,et al.  Dendritic cell–induced autoimmune heart failure requires cooperation between adaptive and innate immunity , 2003, Nature Medicine.

[90]  Yoshimasa Tanaka,et al.  Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice , 2003, Nature Medicine.

[91]  Kunimasa Suzuki,et al.  Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAβ knockout NOD mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[92]  G. Krueger,et al.  Human Herpesvirus-6: A Short Review of Its Biological Behavior , 2003, Intervirology.

[93]  J. Towbin,et al.  Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. , 2003, Journal of the American College of Cardiology.

[94]  H. Schultheiss,et al.  Interferon- (cid:1) Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction , 2003 .

[95]  R. Mobini,et al.  Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. , 2003, Journal of autoimmunity.

[96]  B. Maisch,et al.  Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. , 2003, Human pathology.

[97]  R. Mobini,et al.  Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes. , 2003, European journal of pharmacology.

[98]  G. Thiene,et al.  Immunosuppressive Therapy for Active Lymphocytic Myocarditis: Virological and Immunologic Profile of Responders Versus Nonresponders , 2003, Circulation.

[99]  D. Massi,et al.  Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin. , 2003, Human pathology.

[100]  H. Schultheiss,et al.  Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. , 2003, Circulation.

[101]  S. Ogawa,et al.  Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[102]  D. Hu,et al.  Autoantibodies against the myocardial beta1-adrenergic and M2-muscarinic receptors in patients with congestive heart failure. , 2002, Chinese medical journal.

[103]  M. Yacoub,et al.  Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: immunoglobulin G3 and clinical correlates. , 2002, American heart journal.

[104]  G. Wallukat,et al.  Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. , 2002, Journal of the American College of Cardiology.

[105]  M. Davies,et al.  Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[106]  J. Mason,et al.  Advances in the understanding of myocarditis. , 2001, Circulation.

[107]  G. Wallukat,et al.  Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. , 2001, Journal of molecular and cellular cardiology.

[108]  Romuald Wojnicz,et al.  Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy: Two-Year Follow-Up Results , 2001, Circulation.

[109]  R. Holubkov,et al.  Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy , 2001, Circulation.

[110]  G Thiene,et al.  Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings , 2001, Cardiovascular research.

[111]  Anita Deswal,et al.  Cytokines and Cytokine Receptors in Advanced Heart Failure: An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST) , 2001, Circulation.

[112]  S. Ogawa,et al.  Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. , 2001, Journal of the American College of Cardiology.

[113]  S. Nitter‐Hauge,et al.  Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure , 2001, Circulation.

[114]  P. Chiale,et al.  Autoantibodies in Chagas' Cardiomyopathy and Arrhythmias , 2001, Autoimmunity.

[115]  G. Wallukat,et al.  Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies. , 2000, Journal of the American College of Cardiology.

[116]  R. Hruban,et al.  Echocardiographic findings in fulminant and acute myocarditis. , 2000, Journal of the American College of Cardiology.

[117]  M Pohl,et al.  Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. , 2000, Journal of the American College of Cardiology.

[118]  G. Wallukat,et al.  Autoantibodies against the Beta- and Muscarinic Receptors in Cardiomyopathy , 2000, Herz.

[119]  R. Hruban,et al.  Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. , 2000, The New England journal of medicine.

[120]  B. Strauer,et al.  Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. , 2000, Journal of the American College of Cardiology.

[121]  S. Chu,et al.  Rescue for acute myocarditis with shock by extracorporeal membrane oxygenation. , 1999, The Annals of thoracic surgery.

[122]  R. Hruban,et al.  The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. , 1999, Medicine.

[123]  M. Lohse,et al.  Cardiac Function in Chronic Heart Failure-Adrenergic Receptors Are Associated With Reduced 1 β Autoantibodies Activating Human , 1999 .

[124]  R. Zhao,et al.  Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages. , 1999, Autoimmunity.

[125]  M. Zembala,et al.  Immunohistological diagnosis of myocarditis. Potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury. , 1998, European heart journal.

[126]  O Strohm,et al.  Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. , 1998, Circulation.

[127]  P. Sakkinen,et al.  Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity. , 1998, Advances in virus research.

[128]  T. Treasure,et al.  Meta-analysis of the association of enteroviruses with human heart disease , 1997, Heart.

[129]  B. Strauer,et al.  Cardiac troponin T in patients with clinically suspected myocarditis. , 1997, Journal of the American College of Cardiology.

[130]  B. Maisch,et al.  Antibodies against stress proteins in sera of patients with dilated cardiomyopathy. , 1997, Journal of molecular and cellular cardiology.

[131]  J. Goldman,et al.  Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. The Myocarditis Treatment Trial Investigators. , 1997, European heart journal.

[132]  J. Penninger,et al.  Viral myocarditis: balance between viral infection and immune response. , 1996, The Canadian journal of cardiology.

[133]  B. Diamond,et al.  Autoimmunity in heart disease: mechanisms and genetic susceptibility. , 1996, Molecular medicine today.

[134]  E. Borda,et al.  Antiadrenergic and muscarinic receptor antibodies in Chagas' cardiomyopathy. , 1996, International journal of cardiology.

[135]  S. Matsui,et al.  Characteristic distribution of circulating autoantibodies against G-protein coupled cardiovascular receptors in patients with idiopathic dilated and hypertrophic cardiomyopathy. , 1996, International journal of cardiology.

[136]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[137]  S. Redwood,et al.  Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy. , 1995, British heart journal.

[138]  A. Matsumori,et al.  Dilated cardiomyopathy associated with hepatitis C virus infection. , 1995, Circulation.

[139]  G. Wallukat,et al.  High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities. , 1995, Journal of the American College of Cardiology.

[140]  B. McManus,et al.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. , 1995, The New England journal of medicine.

[141]  G. Wallukat,et al.  Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. , 1995, Journal of molecular and cellular cardiology.

[142]  N. Takekoshi,et al.  Dilated cardiomyopathy defines serum autoantibodies against G-protein-coupled cardiovascular receptors. , 1995, Autoimmunity.

[143]  D. Le Guludec,et al.  Myocardial sarcoidosis. Clinical value of technetium-99m sestamibi tomoscintigraphy. , 1994, Chest.

[144]  M. Gershwin,et al.  Epitope mapping of the branched chain alpha-ketoacid dehydrogenase dihydrolipoyl transacylase (BCKD-E2) protein that reacts with sera from patients with idiopathic dilated cardiomyopathy. , 1994, Journal of immunology.

[145]  L. Mestroni,et al.  Evidence from family studies for autoimmunity in dilated cardiomyopathy , 1994, The Lancet.

[146]  M. Kodama,et al.  Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. , 1994, Circulation research.

[147]  J. Towbin,et al.  Acute Myocarditis : Rapid Diagnosis by PCR in Children 331 TABLE 1 . Dallas Criteria * General definition : Myocardial cell injury with degeneration or necrosis with inflammatory infiltrate not due to ischemia , 2005 .

[148]  G. Wallukat,et al.  Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. , 1994, Circulation.

[149]  T. Martino,et al.  Viral infection and the pathogenesis of dilated cardiomyopathy. , 1994, Circulation research.

[150]  M. Yacoub,et al.  Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. , 1993, Journal of the American College of Cardiology.

[151]  F. Waagstein,et al.  Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. , 1993, The Journal of clinical investigation.

[152]  M. Herzum,et al.  Cytomegalovirus associated inflammatory heart muscle disease. , 1993, Scandinavian journal of infectious diseases. Supplementum.

[153]  W. Mckenna,et al.  Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. , 1992, Circulation.

[154]  K. Klingel,et al.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[155]  G. Wallukat,et al.  Autoantibodies against the β-adrenergic receptor in human myocarditis and dilated cardiomyopathy: β-adrenergic agonism without desensitization , 1991 .

[156]  C. Limas.  Beta-adrenoceptor antibodies and genetics in dilated cardiomyopathy--an overview and review. , 1991, European heart journal.

[157]  J. Herlitz,et al.  Effect of acupuncture in patients with angina pectoris. , 1991, European heart journal.

[158]  G. Wallukat,et al.  Autoantibodies against the beta-adrenergic receptor in human myocarditis and dilated cardiomyopathy: beta-adrenergic agonism without desensitization. , 1991, European heart journal.

[159]  K. Baughman,et al.  Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. , 1990, Journal of the American College of Cardiology.

[160]  F. Camerini,et al.  Advances in Cardiomyopathies , 1990, Springer Berlin Heidelberg.

[161]  I. Palacios,et al.  Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. , 1990, Journal of the American College of Cardiology.

[162]  E. Bonifacio,et al.  Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. , 1990, Journal of the American College of Cardiology.

[163]  D. Denny,et al.  Thallium-201 scintigraphy in the diagnosis and management of myocardial sarcoidosis. , 1990, Southern medical journal.

[164]  H. Schultheiss,et al.  Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function. , 1990, Circulation.

[165]  H. Schultheiss,et al.  Biomolecular Changes in Dilated Cardiomyopathy , 1990 .

[166]  J E Parrillo,et al.  A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. , 1989, The New England journal of medicine.

[167]  H. Schultheiss,et al.  Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. , 1989, American heart journal.

[168]  G. Cremaschi,et al.  Antibodies to beta 1 and beta 2 adrenoreceptors in Chagas' disease. , 1988, Clinical and experimental immunology.

[169]  F. Camerini,et al.  Echocardiographic findings in myocarditis. , 1988, The American journal of cardiology.

[170]  A. Nitenberg,et al.  Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. , 1988, The American journal of medicine.

[171]  K. Welsh,et al.  TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS BY EXTRACORPOREAL IMMUNOADSORPTION , 1988, The Lancet.

[172]  K. Beisel,et al.  Cardiac myosin induces myocarditis in genetically predisposed mice. , 1987, Journal of immunology.

[173]  W. Edwards,et al.  Myocarditis. A histopathologic definition and classification. , 1987, The American journal of cardiovascular pathology.

[174]  H. Thysell,et al.  GOODPASTURE'S SYNDROME TREATED WITH STAPHYLOCOCCAL PROTEIN A IMMUNOADSORPTION , 1985, The Lancet.

[175]  H. Schultheiss,et al.  Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. , 1985, Journal of molecular and cellular cardiology.

[176]  B. Maisch,et al.  Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. , 1984, Clinical and experimental immunology.

[177]  R. Gunnar,et al.  Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis. , 1984, Circulation.

[178]  I. Palacios,et al.  The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure. Endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis. , 1984, Circulation.

[179]  B. Maisch,et al.  Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. , 1983, The American journal of cardiology.

[180]  B. Maisch,et al.  Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. , 1982, Clinical and experimental immunology.

[181]  Woodruff Jf.  Viral myocarditis. A review. , 1980 .

[182]  J. Woodruff.  Viral myocarditis. A review. , 1980, The American journal of pathology.

[183]  C. Oakley,et al.  Antibodies to Coxsackie B viruses in congestive cardiomyopathy. , 1979, British heart journal.

[184]  P. Teychenné,et al.  パーキンソン病におけるレボドーパ(単独またはカルビドーパと併用)とブロモクリプチン , 1976 .

[185]  N. Fowler,et al.  Immunologic findings in idiopathic cardiomyopathy: a prospective serial study. , 1973, American heart journal.

[186]  G. Fletcher,et al.  Autoimmune Studies in Patients with Primary Myocardial Disease , 1968, Circulation.

[187]  O. Saphir,et al.  Myocarditis; a classification of 1402 cases. , 1947, American heart journal.